Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
FCN$160.70-0.70(-0.43%)FTI Consulting Adds Neel Malkani to Help Private Capital Firms and Portfolio Companies Accelerate Value Creation[7:30:00 AM ET]HPQFF$0.080.00(0.00%)Novacium, Axel’One and AD-VENTA Secure €1 Million in RAPID Funding from the DGA and AID for the METAGENE™ Green Hydrogen Project[7:30:00 AM ET]NEXCF$0.040.00(0.00%)Nextech3D.ai Launches AI Assisted Dynamic Booth Pricing, Creating New Transaction-Based Revenue Opportunity[7:30:00 AM ET]ARTV$6.16+0.01(+0.16%)Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®[7:30:00 AM ET]DNGDF$3.670.00(0.00%)Dynacor Group Announces November 2026 Dividend[7:30:00 AM ET]SAGGF$0.740.00(0.00%)Sterling Metals Announces Board and Management Changes[7:30:00 AM ET]TRVI$12.76+0.25(+2.00%)Trevi Therapeutics to Participate in Stifel's 2026 Healthcare Conference[7:30:00 AM ET]WFRD$88.16+1.31(+1.51%)Weatherford Announces Court Approval and Expected Closing Date for U.S. Redomestication[7:30:00 AM ET]SCTLF$0.310.00(0.00%)SalesCloser Launches WhatsApp Integration: AI Sales Agents Now Answer Leads on WhatsApp in Seconds[7:30:00 AM ET]NWFL$34.88+0.11(+0.32%)Norwood Financial Corp announces Third Quarter Financial Results[7:30:00 AM ET]BA$190.35+2.04(+1.08%)Boeing Reports Third Quarter Results Third Quarter 2026 737-7 achieved amended type certification (ATC) from the FAA; 737-10 achieved ATC in October Selected by the U.S. Navy to design,...[7:30:00 AM ET]KNSA$79.00+6.02(+8.25%)Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio Execution[7:30:00 AM ET]OPRX$9.00-0.15(-1.64%)OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel[7:30:00 AM ET]HUBB$451.01-8.39(-1.83%)Hubbell Reports Third Quarter 2026 Results[7:30:00 AM ET]CNSY$1.57-0.07(-4.27%)Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ™ Doses in Leptomeningeal Metastases[7:30:00 AM ET]

NAUT · NASDAQ

Nautilus Biotechnology, Inc.

$2.55 +0.15 (+6.25%)

Company overview

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops the Nautilus Platform, a proteomics platform that includes an end-to-end solution comprising instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$325M
Employees
134
Headquarters
Seattle, WA
Website
nautilus.bio
CEO
Sujal Patel
Listed
August 7, 2020
P/E
-5.57
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$3.1M
Operating income
-$64.1M
EBITDA
-$56.2M
Net income
-$57.1M
EPS
-$0.46
Total assets
$178M
Total debt
$28.9M
Earnings yield
-17.97%

Revenue segmentation

By product

No annual segmentation.

By region

No geographic segmentation.

Price chart

0.741.402.052.703.36
NAUT 1D NASDAQ O2.94H2.94L2.23C2.40-0.84 (-25.92%)Vol4.20M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology Reports Third Quarter 2026 Financial Results GlobeNewswire
NAUTNautilus Biotechnology, Inc. Press release Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium GlobeNewswire
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 GlobeNewswire
NAUTNautilus Biotechnology, Inc. Stock news This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Benzinga
NAUTNautilus Biotechnology, Inc. Press release Nature Methods Publication Reveals Deep Insights into GlobeNewswire
NAUTNautilus Biotechnology, Inc. Stock news 3 Small-Cap Stocks to Buy Before May 15 InvestorPlace
NAUTNautilus Biotechnology, Inc. Stock news Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript Seeking Alpha
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology Reports First Quarter 2026 Financial Results GlobeNewsWire
BRKR Stock news Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard Investor Place
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform GlobeNewsWire
NAUTNautilus Biotechnology, Inc. Stock news Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript Seeking Alpha
NAUTNautilus Biotechnology, Inc. Stock news Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript Seeking Alpha
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference GlobeNewsWire
NAUTNautilus Biotechnology, Inc. Press release Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging GlobeNewsWire
NAUTNautilus Biotechnology, Inc. Stock news Nautilus Biotechnology, Inc. (NAUT) Q3 2025 Earnings Call Transcript Seeking Alpha
See more
FAQ

Questions about Nautilus Biotechnology, Inc.

What does Nautilus Biotechnology, Inc. do?
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops the Nautilus Platform, a proteomics platform that includes an end-to-end solution comprising instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
What is NAUT's market cap?
Nautilus Biotechnology, Inc. (NAUT) is a listed stock with a live quote. The latest market cap on this page is $325M.
Where is Nautilus Biotechnology, Inc. headquartered?
Nautilus Biotechnology, Inc. is headquartered in Seattle, WA.
How do I get NAUT news from the API?
Call GET /v1/news?tickers=NAUT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does NAUT news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for NAUT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the NAUT price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs